By
AmyT on
April 14, 2010
I’m sure many of you heard the news yesterday that Roche Diabetes has acquired Israel-based Medingo, makers of the much-anticipated Solo insulin patch pump — a would-be direct competitor to the OmniPod tubeless pumping system.
Roche paid $160 million for the small company and its technology, which is a drop in the bucket in industry terms. The press release predicts “worldwide availability by 2012.”
In case you’re wondering, the Solo system already had an integrated…
Read more »
By
AmyT on
March 17, 2010
I often wonder what it would be like to have diabetes in a different western industrialized country — one that has a sensible, functioning health care system, for example. Or just someplace smaller, and greener.
This being St. Patrick’s Day, I thought I’d look up Ireland. Here are a some interesting wee tidbits that Google coughed up:
♣ The website of the big national advocacy organization, The Diabetes Federation of Ireland, has much the same content…
Read more »
By
AmyT on
March 10, 2010
Following my series of interviews with Kris Freeman, I got a note from competitive cyclist Phil Southerland, founder of Team Type 1. He wanted to let me know how well his group of athletes with type 1 diabetes have been performing so far this year.
Phil was concerned that the mainstream media coverage of Freeman’s challenges may have stirred up “a lot of negativity about diabetes.” So he asked me if he could submit a…
Read more »
By
AmyT on
December 22, 2009
Last week I learned of yet another company, Echo Therapuetics out of the Boston area, that is developing a transdermal continuous glucose monitoring system for people with diabetes. Naturally that means a non-invasive monitor that takes constant readings through your skin.
Been there. Heard that. Right?
Well, allow me to briefly introduce their work before we get into the discussion about whether skin-surface monitoring will ever succeed.
Echo’s Symphony system is made up of four…
Read more »
By
AmyT on
August 10, 2009
Francine Kaufman is one of the most recognized individuals in the field of diabetes care. She’s a world-renown pediatric endocrinologist at USC, a former ADA president, the author of Diabesity. Late last year, she made the leap to industry, joining Medtronic to become “a key architect of the company’s global diabetes strategy.” Today we’re privileged to hear her thoughts on then, now, and why:
A Guest Post by Dr. Francine Kaufman, Chief Medical Officer, Medtronic…
Read more »
